Vitamin D Gene Regulation

Principles of Bone Biology: Volume 1-2, Third Edition

Volumn , Issue , 2008, Pages 779-794

  Christakos, Sylvia ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77950658080     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-373884-4.00053-7     Document Type: Chapter

References (171)

1. I. Alroy, T.L. Towers and L.P. Freedman (1995) Transcriptional repression of the interleukin 2 gene by vitamin D3. Direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor. Mol. Cell. Biol. 15 5789-5799.
2. M. Amling, M. Priemel, T. Holzmann, K. Chapin, J.M. Rueger, R. Baron and M.B. Demay (1999) Rescue of the skeletal phenotype of vitamin D receptor-ablated mice in the setting of normal mineral ion homeostasis: Formal histomorphometric and biomechanical analyses. Endocrinology 140 4982-4987.
3. N.C. Arbour, J.M. Prahl and H.F. DeLuca (1993) Stabilization of the vitamin D receptor in rat osteosarcoma cells through the action of 1, 25-dihydroxyvitamin D3. Mol. Endocrinol. 7 1307-1312.
4. H.J. Armbrecht, T.V. Zenser and B.B. Davis (1980) Effect of age on the conversion of 25-hydroxyvitamin D3 to 1, 25-dihydroxyvitamin D3 by kidney of rat. J.Clin. Invest. 66 1118-1123.
5. Y. Asou, S. Rittling, H. Yoshitake, K. Tsuji, K. Shinomiya, A. Nifuji, D.T. Denhardt and M. Noda (2001) Osteopontin facilitates angiogenesis, accumulation of osteoclasts, and resorption in ectopic bone. Endocrinology 142 1325-1332.
6. F. Barletta, L.P. Freedman and S. Christakos (2002) Enhancement of VDR-mediated transcription by phosphorylation: Correlation with increased interaction between the VDR and DRIP205, a subunit of the VDR-interacting protein coactivator complex. Mol. Endo. 16 301-314.
7. F. Barletta, P. Dhawan and S. Christakos (2004) Integration of hormone signaling in the regulation of human 25(OH)D3 24-hydroxylase transcription. Am. J. Physiol. 286 E598-eE608.
8. S.N. Baski and A.D. Kenny (1978) Does estradiol stimulate in vivo production of 1, 25-dihydroxyvitamin D3 in the rat? Life Sci. 22 787-792.
9. B.S. Benn, D. Ajibade, A. Porta, P. Dhawan, M. Hediger, J.B. Peng, Y. Jiang, G.T. Oh, E.B. Jeung, L. Lieben, R. Bouillon, G. Carmeliet and S. Christakus (2008) Active intestinal calcium transport in the absence of transient receptor vanilloid type 6 and culbindin-D9k. Endocrinology 149 2196-3205.
10. S.D. Bianco, J.B. Peng, H. Takanaga, Y. Suzuki, A. Crescenzi, C.H. Kos, L. Zhuang, M.R. Freeman, C.H. Gouveia, J. Wu, H. Luo, T. Mauro, E.M. Brown and M.A. Hediger (2007) Marked disturbance of calcium homeostasis in mice with targeted disruption of the Trpv6 calcium channel gene. J. Bone Miner. Res. 22 274-285.
11. J.C.G. Blanco, I.M. Wang, S.Y. Tsai, M.J. Tsai, B.W. O'Malley, P.W. Jurutka, M.R. Haussler and K. Ozato (1995) Transcription factor TFIIB and the vitamin D receptor cooperatively activate ligand dependent transcription. Proc. Natl. Acad. Sci. U. S. A. 92 1535-1539.
12. J.L. Borke, J. Minami, A.K. Verma, J.T. Penniston and R. Kumar (1988) Colocalization of erythrocyte Ca2 + Mg2+ ATPase and vitamin D-dependent 28-kilodalton calcium binding protein in cells of human kidney distal tubules. Kidney Int. 34 262-267.
13. I. Bouhtiauy, D. Lajeunesse, S. Christakos and M.G. Brunette (1994) Two vitamin D-dependent calcium-binding proteins increase calcium reabsorption by different mechanisms. I. Effect of CaBP28k. Kidney Int. 45 461-468.
14. I. Bouhtiauy, D. Lajeunesse, S. Christakos and M.G. Brunette (1994) Two vitamin D-dependent calcium-binding proteins increase calcium reabsorption by different mechanisms. II. Effect of CaBP9k. Kidney Int. 45 469-474.
15. I.T. Boyle, R.W. Gray and H.F. DeLuca (1971) Regulation by calcium of in vitro synthesis of 1, 25-dihdroxycholecalciferol and 24, 25-dihdroxycholecalciferol. Proc. Natl. Acad. Sci. U. S. A. 68 2131-2135.
16. H.L. Brenza and H.F. DeLuca (2000) Regulation of 25-hydroxyvitamin D3 1alpha-hydroxylase gene expression by parathyroid hormone and 1, 25-dihydroxyvitamin D3. Arch. Biochem. Biophys. 381 143-152.
17. H.L. Brenza, C. Kimmel-Jehan, F. Jehan, T. Shinki, S. Wakino, H. Anazawa, T. Suda and H.F. DeLuca (1998) Parathyroid hormone activation of the 25-hydroxyvitamin D3-1alpha-hydroxylase gene promoter. Proc. Natl. Acad. Sci. U. S. A. 95 1387-1391.
18. Q. Cai, J.S. Chandler, R.H. Wasserman, R. Kumar and J.T. Penniston (1993) Vitamin D and adaptation to dietary calcium and phosphate deficiency increase intestinal plasma membrane calcium pump gene expression. Proc. Natl. Acad. Sci. U. S. A. 90 1345-1349.
19. M.T. Cantorna, W.D. Woodward, C.E. Hayes and H.F. DeLuca (1998) 1, 25 Dihydroxy vitamin D3 is a positive regulator for two anti-encephalitogeni cytokines, TGF-beta1 and IL-4. J. Immunol. 160 5314-5319.
20. M. Centrella, S. Christakos and T.L. McCarthy (2004) Skeletal hormones and the C/EBP and Runx transcription factors: Interactions that integrate and redefine gene expression. Gene 342 13-24.
21. Q. Chang, S. Hoefs, A.W. van der Kemp, C.N. Topala, R.J. Bindels and J.G. Hoenderop (2005) The beta-glucuronidase klotho hydrolyzes and activates the TRPV5 channel. Science 310 490-493.
22. B.S. Chertow, W.I. Sivitz, N.G. Baranetsky, S.A. Clark, A. Waite and H.F. DeLuca (1983) Cellular mechanisms of insulin release: The effect of vitamin D deficiency and repletion on rat insulin secretion. Endocrinology 113 1511-1518.
23. B. Cheskis and L.P. Freedman (1994) Ligand modulates the conversion of DNA-bound vitamin D receptor (VDR) homodimer into VDR-Retinoid X receptor heterodimer. Mol. Cell. Biol. 14 3329-3338.
24. S. Christakos (1995) Vitamin D-dependent calcium-binding proteins: Chemistry distribution, functional considerations, and molecular biology: Update 1995. Endocr. Rev. Monogr. 4 108-110.
25. S. Christakos, P. Dhawan, B. Benn, A. Porta, M. Hediger, G.T. Oh, E.B. Jeung, Y. Zhong, D. Ajibade, K. Dhawan and S. Joshi (2007) Vitamin D: molecular mechanism of action. Annals NY Acad. Sci. 1116 340-348.
26. S. Christakos, P. Dhawan, Y. Liu, X. Peng and A. Porta (2003) New insights into the mechanisms of vitamin D action. J. Cell. Biochem. 88 695-705.
27. S. Christakos, P. Dhawan, Q. Shen, X. Peng, B. Benn and Y. Zhong (2006) New insights into the mechanisms involved in the pleiotropic actions of 1, 25dihydroxyvitamin D3. Ann. N. Y. Acad. Sci. 1068 194-203.
28. S. Christakos, C. Gabrielides and W.B. Rhoten (1989) Vitamin D-dependent calcium-binding proteins: Chemistry, distribution, functional considerations, and molecular biology. Endocr. Rev. 10 3-26.
29. S. Christakos and A.W. Norman (1979) Studies on the mode of action of calciferol XIII: Evidence for a high affinity binding protein for 1, 25-dihydroxyvitamin D3 in chick kidney and pancreas. Biochem. Biophys. Res. Commun. 89 56-63.
30. S. Christakos, M. Raval-Pandya, R.P. Wernyj and W. Yang (1996) Genomic mechanisms involved in the pleiotropic actions of 1, 25dihydroxyvitamin D3. Biochem. J. 316 361-371.
31. S.A. Clark, W.E. Stumpf and M. Sar (1981) Effect of 1, 25-dihydroxyvitamin D3 on insulin secretion. Diabetes 30 382-386.
32. M. Cippitelli and A. Santoni (1998) Vitamin D3: A transcriptional modulator of the interferon-gamma gene. Eur. J. Immunol. 28 3017-3030.
33. S. Colnot, B. Romagnolo, M. Lambert, F. Cluzeaud, A. Porteu, A. Vandewalle, M. Thomasset, A. Kahn and C. Perret (1998) Intestinal expression of calbindin-D9k gene in transgenic mice. J. Biol. Chem. 273 31939-31946.
34. E.M. Costa, M.A. Hirst and D. Feldman (1985) Regulation of 1, 25-dihydroxyvitamin D3 receptors by vitamin D analogs in cultured mammalian cells. Endocrinology 117 2203-2210.
35. H.M. Darwish and H.F. DeLuca (1992) Identification of a 1, 25-dihydroxyvitamin D3 response element in the 5’ flanking region of the rat calbindin-D9k gene. Proc. Natl. Acad. Sci. U. S. A. 89 603-607.
36. H.F. DeLuca (2004) Overview of general physiologic features and functions of vitamin D. Amer. J. Clin. Nutr. 80 1689S-ss1696S.
37. M.B. Demay, J.M. Gerardi, H.F. DeLuca and H.M. Kronenberg (1990) DNA sequences in the rat osteocalcin gene that bind the 1, 25-dihydroxyvitamin D3 receptor and confer responsiveness to 1, 25-dihydroxyvitamin D3. Proc. Natl. Acad. Sci. U. S. A. 87 369-373.
38. M.B. Demay, M.S. Kiernan, H.F. DeLuca and H.M. Kronenberg (1992) Sequences in the human parathyroid hormone gene that bind the 1, 25-dihydroxyvitamin D3 receptor and mediate transcriptional repression in response to 1, 25-dihydroxyvitamin D3. Proc. Natl. Acad. Sci. U. S. A. 89 8097-8101.
39. D.T. Denhardt and X. Guo (1993) Osteopontin: A protein with diverse functions. FASEB J. 7 1475-1482.
40. P. Dhawan, X. Peng, A.L. Sutton, P.N. MacDonald, C.M. Croniger, C. Trautwein, M. Centrella, T.L. McCarthy and S. Christakos (2005) Functional cooperation between CCAAT/enhancer-binding proteins and the vitamin D receptor in regulation of 25-hydroxyvitamin D3 24-hydroxylase. Mol. Cell Biol. 25 472-487.
41. J.K. Dhesi, S.H. Jackson, L.M. Bearne, C. Moniz, M.V. Hurley, C.G. Swift and T.J. Allain (2004) Vitamin D supplementation improves neuromuscular function in older people who fall. Age Aging 33 589-595.
42. P.P. Dwivedi, J.L. Omdahl, I. Kola, D.A. Hume and B.K. May (2000) Regulation of rat cytochrome P450C24 (CYP24) gene expression. J. Biol. Chem. 275 47-55.
43. L. Esteban, M. Vidal and A. Dusso (2004) 1alpha-Hydroxylase transactivation by gamma-interferon in murine macrophages requires enhanced C/EBPbeta expression and activation. J. Steroid Biochem. Mol. Biol. 89-90. 131–137
44. L.P. Freedman, V. Arce and R. Perez-Fernandez (1994) DNA sequences that act as high affinity targets for the vitamin D receptor in the absence of the retinoid X receptor. Mol. Endocrinol 8 265-273.
45. P.A. Friedman and F.A. Gesek (1993) Vitamin D3 accelerates PTH-dependent calcium transport in distal convoluted tubule cells. Am. J. Physiol. 265 F300-ffF308.
46. E.M. Gardiner, P.A. Baldock, G.P. Thomas, N.A. Sims, N.K. Henderson, B. Hollis, C.P. White, K.L. Sunn, N.A. Morrison, W.R. Walsh and J.A. Eisman (2000) Increased formation and decreased resorption of bone in mice with elevated vitamin D receptor in mature cells of the osteoblastic lineage. FASEB J. 14 1908-1916.
47. R.K. Gill and S. Christakos (1993) Identification of sequence elements in mouse calbindin- D28k gene that confers 1, 25-dihydroxyvitamin D3 and butyrate inducible responses. Proc. Natl. Acad. Sci. U. S. A. 90 2984-2988.
48. J.M. Gonzalez-Sancho, M.J. Larriba, P. Ordonez-Moran, H.G. Palmer and A. Munoz (2006) Effects of 1alpha, 25-dihydroxyvitamin D3 in human colon cancer cells. Anticancer Res. 26 2669-2681.
49. M.D. Griffin, W. Lutz, V.A. Phan, L.A. Bachman, D.J. McKean and R. Kumar (2001) Dendritic cell modulation by 1alpha, 25 dihydroxyvitamin D3 and its analogs: A vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo. Proc Natl Acad Sci U. S. A. 98 6800-6805.
50. B. Guo, F. Aslam, A.J. van Wijnen, S.G.E. Roberts, B. Frenkel, M.R. Green, H. DeLuca, J.B. Lian, G.S. Stein and J.L. Stein (1997) YY1 regulates vitamin D receptor/retinoid x receptor mediated transactivation of the vitamin D responsive osteocalcin gene. Proc. Natl. Acad. Sci. U. S. A. 94 121-126.
51. S. Gutierrez, A. Javed, D.K. Tennant, M. van Rees, M. Montecino, G.S. Stein, J.L. Stein and J.B. Lian (2002) CCAAT/enhancer-binding proteins (C/EBP) beta and delta activate osteocalcin gene transcription and synergize with Runx2 at the C/EBP element to regulate bone-specific expression. J. Biol. Chem. 277 1316-1323.
52. K.D. Healy, M.A. Frahm and H.F. DeLuca (2005) 1, 25-Dihydroxyvitamin D3 upregulates the renal vitamin D receptor through indirect gene activation and receptor stabilization. Arch. Biochem. Biophys 433 466-473.
53. K.D. Healy, J.L. Vanhooke, J.M. Prahl and H.F. DeLuca (2005) Parathyroid hormone decreases renal vitamin D receptor expression in vivo. Proc. Natl. Acad. Sci. U. S. A. 102 4724-4728.
54. K.D. Healy, J.B. Zella, J.M. Prahl and H.F. DeLuca (2003) Regulation of the murine renal vitamin D receptor by 1, 25-dihydroxyvitamin D3 and calcium. Proc. Natl. Acad. Sci. U. S. A. 100 9733-9737.
55. H. Henry (1985) Parathyroid modulation of 25-hydroxyvitamin D3 metabolism by cultured chick kidney cells is mimicked and enhanced by forskolin. Endocrinology 116 503-510.
56. G.M. Hilliard, R.G. Cook, N.L. Weigel and J.W. Pike (1994) 1, 25-Dihydroxyvitamin D3 modulates phosphorylation of serine 205 in the vitamin D receptor: Site directed mutagenesis of this residue promotes alternative phosphorylation. Biochemistry 33 4300-4311.
57. E.R. Hines, O.I. Kolek, M.D. Jones, S.H. Serey, N.B. Sirjani, P.R. Kiela, P.W. Jurutka, M.R. Haussler, J.F. Collins and F.K. Ghishan (2004) 1, 25-dihydroxyvitamin D3 downregulation of PHEX gene expression is mediated by apparent repression of a 110kDa transfactor that binds to a polyadenine element in the promoter. J. Biol. Chem. 279 46406-46414.
58. J.G.J. Hoenderop, A.W.C.M. van der Kemp, A. Hartog, S.F.J. van de Graaf, C.H. Van Os, P.H.G.M. Willems and R.J.M. Bindels (1999) Molecular identification of the apical Ca2+ channel in 1, 25-dihydroxyvitamin D-responsive epithelia. J. Biol. Chem. 274 8375-8378.
59. J.G.J. Hoenderop, J.P. van Leeuwen, B.C. van der Eerden, F.F. Kersten, A.W. van der Kemp, A.M. Merillat, J.H. Waarsing, B.C. Rossier, V. Vallon, E. Hummler and R.J. Bindels (2003) Renal Ca2+ wasting, hyperabsorption, and reduced bone thickness in mice lacking TRPV5. J. Clin. Invest. 112 1906-1914.
60. Y.C. Huang, S. Lee, R. Stolz, C. Gabrielides, A. Pansini-Porta, M.E. Bruns, D. Bruns, T. Mifflin, J.W. Pike and S. Christakos (1989) Effect of hormones and development on the expression of the rat 1, 25-dihydroxyvitamin D3 receptor gene: Comparison with calbindin gene expression. J. Biol. Chem. 264 17454-17461.
61. M. Huening, G. Yehia, C.A. Molina and S. Christakos (2002) Evidence for a regulatory role of inducible cAMP early repressor in protein kinase a-mediated enhancement of vitamin D receptor expression and modulation of hormone action. Mol. Endocrinol. 16 2052-2064.
62. T. Inoue, J. Kamiyama and T. Sakai (1999) Sp1 and NF-Y synergistically mediate the effect of vitamin D(3) in the p27(Kip1) gene promoter that lacks vitamin D response elements. J. Biol. Chem. 274 32309-32317.
63. A. Javed, S. Gutierrez, M. Montecino, A.J. van Wijnen, J.L. Stein, G.S. Stein and J.B. Lian (1999) Multiple Cbfa/AML sites in the rat osteocalcin promoter are required for basal and vitamin-D responsive transcription and contribute to chromatin organization. Mol. Cell. Biol. 19 7491-7500.
64. A.M. Jimenez-Lara and A. Aranda (1999) Lysine 246 of the vitamin D receptor is crucial for the ligand-dependent interaction with coactivators and transcriptional activity. J. Biol. Chem. 274 13503-13510.
65. C.H. Jin, S.A. Kerner, M.H. Hong and J.W. Pike (1996) Transcriptional activation and dimerization functions in the human vitamin D receptor. Mol. Endocrinol. 10 945-957.
66. P.W. Jurutka, J.C. Hsieh, P.N. MacDonald, C.M. Terpening, C.A. Haussler, M.R. Haussler and G.K. Whitfield (1993) Phosphorylation of serine 208 in the human vitamin D receptor. J. Biol. Chem. 268 6791-6799.
67. P.W. Jurutka, J.C. Hsieh, S. Nakajima, C.A. Haussler, G.K. Whitfield and M.R. Haussler (1996) Human vitamin D receptor phosphorylation by casein kinase II at Ser-208 potentiates transcriptional activation. Proc. Natl. Acad. Sci. U. S. A. 93 3519-3524.
68. S.A. Kerner, R.A. Scott and J.W. Pike (1989) Sequence elements in the human osteocalcin gene confer basal activation and inducible response to hormonal vitamin D3. Proc. Natl. Acad. Sci. U. S. A. 86 4455-4459.
69. D.M. Kerry, P.P. Dwivedi, C.N. Hahn, H.A. Morris, J.L. Omdahl and B.K. May (1996) Transcriptional synergism between vitamin D-responsive elements in the rat 25-hydroxyvitamin D3 24-hydroxylase (CYP24) promoter. J. Biol. Chem. 271 29715-29721.
70. S. Kim, M. Yamazaki, N.K. Shevde and J.W. Pike (2007) Transcriptional control of receptor activator of nuclear factor-kappaB ligand by the protein kinase A activator forskolin and the transmembrane glycoprotein 130-activating cytokine, oncostatin M, is exerted through multiple distal enhancers. Mol. Endocrinol. 21 197-214.
71. K. Kinuta, H. Tanaka, T. Moriwake, K. Aya, S. Kato and Y. Seino (2000) Vitamin D is an important factor in estrogen biosynthesis of both female and male gonads. Endocrinology 141 1317-1324.
72. D.M. Kraichely, J.J. Collins, R.K. DeLisle and P.N. MacDonald (1999) The autonomous transactivation domain in helix 3 of the vitamin D receptor is required for transactivation and coactivator interaction. J. Biol. Chem. 274 14352-14358.
73. A.V. Krishnan, S.D. Cramer, F.R. Bringhurst and D. Feldman (1995) Regulation of 1, 25-dihydroxyvitamin D3 receptors by parathyroid hormone in osteoblastic cells: Role of second messenger pathways. Endocrinology 136 705-712.
74. A.V. Krishnan and D. Feldman (1991) Activation of protein kinase C inhibits vitamin D receptor gene expression. Mol. Endocrinol. 5 605-612.
75. A.V. Krishnan and D. Feldman (1992) Cyclic adenosine 3'5’ monophosphate upregulates 1, 25-dihydroxyvitamin D3 receptor gene expression and enhances hormone action. Mol. Endocrinol. 6 198-206.
76. A.V. Krishnan, D.M. Peehl and D. Feldman (2003) The role of vitamin D in prostate cancer. Recent Results Cancer Res. 164 205-221.
77. J. Krisinger, M. Strom, H.D. Darwish, K. Perlman, C. Smith and H.F. DeLuca (1991) Induction of calbindin-D9k mRNA but not calcium transport in rat intestine by 1, 25-dihydroxyvitaminD3 24-homologs. J. Biol. Chem. 266 1910-1913.
78. M. Kuro-o (2006) Klotho as a regulator of fibroblast growth factor signaling and phosphate/calcium metabolism. Curr. Opin. Nephrol. Hypertens. 15 437-441.
79. G.D. Kutuzova, S. Akhter, S. Christakos, J. Vanhooke, C. Kimmel-Jehan and H.F. Deluca (2006) Calbindin D(9k) knockout mice are indistinguishable from wild-type mice in phenotype and serum calcium level. Proc. Natl. Acad. Sci. U. S. A. 103 12377-12381.
80. T.T. Lambers, F. Mahieu, E. Oancea, L. Hoofd, F. de Lange, A.R. Mensenkamp, T. Voets, B. Nilius, D.E. Clapham, J.G. Hoenderop and R.J. Bindels (2006) Calbindin-D28K dynamically controls TRPV5-mediated Ca2+ transport. EMBO J. 25 2978-2988.
81. T.T. Lambers, A.F. Weidema, B. Nilius, J.G. Hoenderop and R.J. Bindels (2004) Regulation of the mouse epithelial Ca2(+) channel TRPV6 by the Ca(2+)-sensor calmodulin. J. Biol. Chem. 279 28855-28861.
82. A.C. Lavigne, G. Mengus, Y.G. Gangloff, J.M. Wurtz and I. Davidson (1999) Human TAFII55 interacts with the vitamin D3 and thyroid hormone receptors and with derivatives of the retinoid x receptor that have altered transactivation properties. Mol. Cell. Biol. 19 5486-5494.
83. Y. Lee, M. Inaba, H.F. DeLuca and W.S. Mellon (1989) Immunological identification of 1, 25-dihydroxyvitamin D3 receptor in human promyelocytic leukemia cells (HL-60) during homologous regulation. J. Biol. Chem. 264 13701-13705.
84. D. Lee, A.G. Obukhov, Q. Shen, Y. Liu, P. Dhawan, M.C. Nowycky and S. Christakos (2006) Calbindin-D28k decreases L-type calcium channel activity and modulates intracellular calcium homeostasis in response to K+ depolarization in a rat beta cell line RINr1046-38. Cell Calcium. 39 475-485.
85. Y.C. Li, A.E. Pirro, M. Amling, G. Delling, R. Baron, R. Bronson and M.B. Demay (1997) Targeted ablation of the vitamin D receptor: An animal model of vitamin D-dependent rickets type II with alopecia. Proc. Natl. Acad. Sci. U. S. A. 94 9831-9835.
86. Y.C. Li, A.E. Pirro and M.B. Demay (1998) Analysis of vitamin D-dependent calcium binding protein messenger ribonucleic acid expression in mice lacking the vitamin D receptor. Endocrinology 139 847-851.
87. J.B. Lian, J.L. Stein, G.S. Stein, M. Montecino, A.J. van Wijnen, A. Javed and S. Gutierrez (2001) Contributions of nuclear architecture and chromatin to vitamin D-dependent transcriptional control of the rat osteocalcin gene. Steroids 66 159-170.
88. M. Liu, M.-H. Lee, M. Cohen, M. Bommakanti and L.P. Freedman (1996) Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev. 10 142-153.
89. P.T. Liu, S. Stenger, H. Li, L. Wenzel, B.H. Tan, S.R. Krutzik, M.T. Ochoa, J. Schauber, K. Wu, C. Meinken, D.L. Kamen, M. Wagner, R. Bals, A. Steinmeyer, U. Zugel, R.L. Gallo, D. Eisenberg, M. Hewison, B.W. Hollis, J.S. Adams, B.R. Bloom and R.L. Modlin (2006) Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311 1770-1773.
90. Y. Liu, Q. Shen, P.J. Malloy, E. Soliman, X. Peng, S. Kim, J.W. Pike, D. Feldman and S. Christakos (2005) Enhanced coactivator binding and transcriptional activation of mutant vitamin D receptors from patients with hereditary 1, 25-dihydroxyvitamin D-resistant rickets by phosphorylation and vitamin D analogs. J. Bone Miner. Res. 20 1680-1691.
91. L. Lowe, C.M. Hansen, S. Senaratne and K.W. Colston (2003) Mechanisms implicated in the growth regulatory effects of vitamin D compounds in breast cancer cells. Recent Results Cancer Res. 164 99-110.
92. P.N. MacDonald, D.R. Dowd, S. Nakajima, M.A. Galligan, M.C. Reeder, C.A. Haussler, K. Ozato and M.R. Haussler (1993) Retinoid X receptors stimulate and 9cis retinoic acid inhibits 1, 25-dihydroxyvitamin D3 activated expression of the rat osteocalcin gene. Mol. Cell. Biol. 13 5907-5917.
93. S.L. Mackey, J.L. Heymont, H.M. Kronenberg and M.B. Demay (1996) Vitamin D receptor binding to the negative human parathyroid hormone vitamin D response element does not require the retinoid x receptor. Mol. Endocrinol. 10 298-305.
94. K.J. Martin and E.A. Gonzalez (2004) Vitamin D analogs: Actions and role in the treatment of secondary hyperparathyroidism. Semin. Nephrol. 24 456-459.
95. H. Masuyama, S.C. Jefcoat and P.N. MacDonald (1997) The N-terminal domain of transcription factor IIB is required for direct interaction with the vitamin D receptor and participates in vitamin D-mediated transcription. Mol. Endocrinol. 11 218-228.
96. T. Matkovits and S. Christakos (1995) Variable in vivo regulation of rat vitamin D dependent genes (osteopontin, Ca, Mg-Adenosine Triphosphatase, and 25-hydroxyvitamin D3 24-hydroxylase): Implications for differing mechanisms of regulation and involvement of multiple factors. Endocrinology 136 3971-3982.
97. N.J. McKenna, J. Xu, Z. Nawaz, S.Y. Tsai, M.J. Tsai and B.W. O'Malley (1999) Nuclear receptor coactivators: Multiple enzymes, multiple complexes, multiple functions. J. Steroid Biochem. Mol. Biol. 69 3-12.
98. C. Mengus, M. May, L. Carre, P. Chambon and I. Davidson (1997) Human TAFII135 potentiates transcriptional activation by the AF-2 s of the retinoic acid, vitamin D3 and thyroid hormone receptors in mammalian cells. Genes Dev. 11 1381-1395.
99. G. Mengus, Y.G. Gangloff, L. Carre, A.C. Lavigne and I. Davidson (2000) The human transcription factor II D subunit human TATA-binding protein-associated factor 28 interacts in a ligand-reversible manner with the vitamin D3 and thyroid hormone receptors. J. Biol. Chem. 275 10064-10071.
100. M.B. Meyer, M. Watanuki, S. Kim, N.K. Shevde and J.W. Pike (2006) The human transient receptor potential vanilloid type 6 distal promoter contains multiple vitamin D receptor binding sites that mediate activation by 1, 25-dihydroxyvitamin D3 in intestinal cells. Mol. Endocrinol. 20 1447-1461.
101. K. Miyamoto, R.A. Kesterson, H. Yamamoto, Y. Taketani, E. Nishiwaki, S. Tatsumi, Y. Inoue, K. Morita, E. Takeda and J.W. Pike (1997) Structural organization of the human vitamin D receptor chromosomal gene and its promoter. Mol. Endocrinol. 11 1165-1179.
102. R.L. Morrissey, T.J. Bucci, R.N.J. Empson and E.G. Lufkin (1975) Calcium binding protein: Its cellular localization in jejunum, kidney, and pancreas. Proc. Soc. Exp. Biol. Med. 149 56-60.
103. A. Murayama, K. Takeyama, S. Kitanaka, Y. Kodera, Y. Kawaguchi, T. Hosoya and S. Kato (1999) Positive and negative regulations of the renal 25-hydroxyvitamin D3 1α-hydroxylase gene by parathyroid hormone, calcitonin and 1α, 25(OH)2D3 in intact animals. Endocrinology. 140 2224-2231.
104. A. Murayama, M.S. Kim, J. Yanagisawa, K. Takeyama and S. Kato (2004) Transrepression by a liganded nuclear receptor via a bHLH activator through co-regulator switching. EMBO J. 23 1598-1608.
105. S. Nakajima, J.-C. Hsieh, P.N. MacDonald, M.A. Galligan, C.A. Haussler, G.K. Whitfield and M.R. Haussler (1994) The C terminal region of the vitamin D receptor is essential to form a complex with a receptor auxiliary factor required for high affinity binding to the vitamin D responsive element. Mol. Endocrinology 8 159-172.
106. T. Naveh-Many, R. Marx, E. Keshet, J.W. Pike and J. Silver (1990) Regulation of 1, 25-dihydroxyvitamin D3 receptor gene expression by 1, 25-dihydroxyvitamin D3 in the parathyroid in vivo. J. Clin. Invest. 86 1968-1975.
107. J. Nishikawa, M. Kitaura, M. Matsumoto, M. Imagawa and T. Nishihara (1994) Difference and similarity of DNA sequences recognized by VDR homodimer and VDR/RXR heterodimer. Nucleic Acids Res. 22 2902-2907.
108. M. Noda, R.L. Vogel, A.M. Craig, J. Prahl, H.F. DeLuca and D.T. Denhardt (1990) Identification of a DNA sequence responsible for binding of the 1, 25-dihydroxyvitamin D3 receptor and 1, 25-dihydroxyvitamin enhancement of mouse secreted phosphoprotein 1 (Supp-1 or osteopontin) gene expression. Proc. Natl. Acad. Sci. U. S. A. 87 9995-9999.
109. A.W. Norman, B.J. Frankel, A.M. Heldt and G.M. Grodsky (1980) Vitamin D deficiency inhibits pancreatic secretion of insulin. Science 209 823-825.
110. A. Nykjaer, D. Dragun, D. Walther, H. Vorum, C. Jacobsen, J. Herz, F. Melsen, E.I. Christensen and T.E. Willnow (1999) An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3. Cell 96 507-515.
111. Y. Ohyama, K. Ozono, M. Uchida, M. Yoshimura, T. Shinki, T. Suda and O. Yamamoto (1996) Functional assessment of two vitamin D-responsive elements in the rat 25-hydroxyvitamin D3 24-hydroxylase gene. J. Biol. Chem. 271 30381-30385.
112. J.L. Omdahl, E.V. Bobrovnikova, A. Annalora, P. Chen and R. Serda (2003) Expression, structure-function, and molecular modeling of vitamin D P450s. J. Cell Biochem. 88 356-362.
113. D.K. Panda, D. Miao, M.L. Tremblay, J. Sirois, R. Farookhi, G.N. Hendy and D. Goltzman (2001) Targeted ablation of the 25-hydroxyvitamin D 1alpha-hydroxylase enzyme: Evidence for skeletal, reproductive, and immune dysfunction. Proc. Natl. Acad. Sci. U. S. A. 98 7498-7503.
114. J.B. Peng, X.Z. Chen, U.V. Berger, P.M. Vassilev, H. Tsukaguchi, E.M. Brown and M.A. Hediger (1999) Molecular cloning and characterization of a channel-like transporter mediating intestinal calcium absorption. J. Biol. Chem. 274 22739-22746.
115. G. Penna and L. Adorini (2000) 1 Alpha, 25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T-cell activation. J. Immunol. 164 2405-2411.
116. F. Perwad, N. Azam, M.Y. Zhang, T. Yamashita, H.S. Tenenhouse and A.A. Portale (2005) Dietary and serum phosphorus regulate fibroblast growth factor 23 expression and 1, 25-dihydroxyvitamin D metabolism in mice. Endocrinology 146 5358-5364.
117. J.W. Pike, E. Spanos, K.W. Colston, I. MacIntyre and M.R. Haussler (1978) Influence of estrogen on renal vitamin D hydroxylases and serum 1α, 25(OH)2D3 in chicks. Am. J. Physiol. 235 E338-eeE343.
118. P.A. Price and S.A. Baukol (1980) 1, 25-Dihydroxyvitamin D3 increases synthesis of the vitamin K-dependent bone protein by osteosarcoma cells. J. Biol. Chem. 255 11660-11663.
119. C.W. Prince and W.T. Butler (1987) 1, 25-Dihydroxyvitamin D3 regulates the biosynthesis of osteopontin, a bone-derived cell attachment protein in clonal osteoblast-like osteosarcoma cells. Collagen Relat. Res. 7 305-313.
120. C. Rachez, B.D. Lemon, Z. Suldan, V. Bromleigh, M. Gamble, A.M. Naar, H. Erdjument-Bromage, P. Tempst and L.P. Freedman (1999) Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex. Nature 398 824-828.
121. C. Rachez, Z. Suldan, J. Ward, C.P. Chang, D. Burakov, H. Erdjument-Bromage, P. Tempst and L.P. Freedman (1998) A novel protein complex that interacts with the vitamin D3 receptor in a ligand-dependent manner and enhances VDR transactivation in a cell-free system. Genes and Dev. 12 1787-1800.
122. L.G. Raisz, C.L. Trammel, M.F. Holick and H.F. DeLuca (1972) 1, 25-Dihydroxyvitamin D3: A potent stimulator of bone resorption in tissue culture. Science 175 768-769.
123. M. Raval-Pandya, P. Dhawan, F. Barletta and S. Christakos (2001) YY1 represses vitamin D receptor-mediated 25-hydroxyvitamin D(3)24-hydroxylase transcription: Relief of repression by CREB-binding protein. Mol. Endocrinol. 15 1035-1046.
124. T.A. Reinhardt and R.L. Horst (1990) Parathyroid hormone down-regulates 1, 25-dihydroxyvitamin D3 receptor (VDR) messenger ribonucleic acid in vitro and blocks homologous upregulation of VDR in vivo. Endocrinology 127 942-948.
125. T.A. Reinhardt and R.L. Horst (1994) Phorbol 12-myristate 13-acetate and 1, 25-dihydroxyvitamin D3 regulate 1, 25-dihydroxyvitamin D3 receptors synergistically in rat osteosarcoma cells. Mol. Cell. Endocrinol. 101 159-165.
126. W.B. Rhoten, M.E. Bruns and S. Christakos (1985) Presence and localization of two vitamin D-dependent calcium-binding proteins in kidneys of higher vertebrates. Endocrinology 117 674-683.
127. N. Rochel, J.M. Wurtz, A. Mitschler, B. Klaholz and D. Moras (2000) The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand. Mol.Cell 5 173-179.
128. E.D. Rosen, E.G. Beninghof and R.J. Koenig (1993) Dimerization interfaces of thyroid hormone, retinoic acid, vitamin D, and retinoid X receptors. J. Biol. Chem. 268 11534-11541.
129. S. Segaert and R. Bouillon (1998) Vitamin D and regulation of gene expression. Curr. Opin. Clin. Nutr. Metab. Care 1 347-354.
130. Q. Shen and S. Christakos (2005) The vitamin D receptor, Runx2, and the Notch signaling pathway cooperate in the transcriptional regulation of osteopontin. J. Biol. Chem. 280 40589-40598.
131. N.K. Shevde, L.A. Plum, M. Clagett-Dame, H. Yamamoto, J.W. Pike and H.F. DeLuca (2002) A potent analog of 1alpha, 25-dihydroxyvitamin D3 selectively induces bone formation. Proc. Natl. Acad. Sci. U. S. A. 99 13487-13491.
132. T. Shimada, M. Kakitani, Y. Yamazaki, H. Hasegawa, Y. Takeuchi, T. Fujita, S. Fukumoto, K. Tomizuka and T. Yamashita (2004) Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J. Clin. Invest. 113 561-568.
133. T. Shinki, C.H. Jin, A. Nishimura, Y. Nagai, Y. Ohyama, M. Noshiro, K. Okuda and T. Suda (1992) Parathyroid hormone inhibits 25-hydroxyvitamin D3-24-hydroxylase mRNA expression stimulated by 1α25-dihydroxyvitamin D3 in rat kidney but not in intestine. J. Biol. Chem. 267 13757-13762.
134. T. Shinki, H. Shimada, S. Wakino, H. Anazawa, M. Hayashi, T. Saruta, H.F. DeLuca and T. Suda (1997) Cloning and expression of rat 25-hydroxyvitamin D3 1α-hydroxylase cDNA. Proc. Natl. Acad. Sci. U. S. A. 94 12920-12925.
135. T. Shinki, Y. Ueno, H.F. DeLuca and T. Suda (1999) Calcitonin is a major regulator for the expression of renal 25-hydroxyvitamin D3-1alpha-hydroxylase gene in normocalcemic rats. Proc. Natl. Acad. Sci. U. S. A. 96 8253-8258.
136. C.L. Smith and B.W. O'Malley (2004) Coregulator function: A key to understanding tissue specificity of selective receptor modulators. Endocr. Rev. 25 45-71.
137. W.B. Sneddon, E.L. Barry, B.A. Coutermarsh, F.A. Gesek, F. Liu and P.A. Friedman (1998) Regulation of renal parathyroid hormone receptor expression by 1, 25-dihydroxyvitamin D3 and retinoic acid. Cell. Physiol. Biochem. 8 261-277.
138. Y. Song, X. Peng, A. Porta, H. Takanaga, J.B. Peng, M.A. Hediger, J.C. Fleet and S. Christakos (2003) Calcium transporter 1 and epithelial calcium channel messenger ribonucleic acid are differentially regulated by 1, 25 dihydroxyvitamin D3 in the intestine and kidney of mice. Endocrinology 144 3885-3894.
139. K. Sooy, T. Schermerhorn, M. Noda, M. Surana, W.B. Rhoten, M. Meyer, N. Fleischer, G.W.G. Sharp and S. Christakos (1999) Calbindin-D28k controls [Ca2+]i and insulin release. J. Biol. Chem. 274 34343-34349.
140. R. St-Arnaud, A. Arabian, R. Travers, F. Barletta, M. Raval-Pandya, K. Chapin, J. Depovere, C. Mathieu, S. Christakos, M.B. Demay and F.H. Glorieux (2000) Deficient mineralization of intramembranous bone in vitamin D-24-hydroxylase-ablated mice is due to elevated 1, 25-dihydroxyvitamin D and not to the absence of 24, 25-dihydroxyvitamin D. Endocrinology 141 2658-2666.
141. K. Stoffels, L. Overbergh, R. Bouillon and C. Mathieu (2007) Immune regulation of 1alpha-hydroxylase in murine peritoneal macrophages: Unravelling the IFNgamma pathway. J. Steroid Biochem. Mol. Biol. 103 567-571.
142. T. Suda (1989) The role of 1, 25-dihydroxyvitamin D3 in the myeloid cell differentiation. Proc. Soc. Exp. Biol. Med. 191 214-220.
143. S. Takeda, T. Yoshizawa, Y. Nagai, H. Yumato, S. Fukumoto, K. Sekine, S. Kato, T. Matsumoto and T. Fujita (1999) Stimulation of osteoclast formation by 1, 25–dihydroxyvitamin D requires its binding to vitamin D receptor (VDR) in osteoblastic cells: Studies using VDR knockout mice. Endocrinology 140 1005-1008.
144. K. Takeyama, S. Kitanaka, T. Sato, M. Kobori, J. Yanagisawa and S. Kato (1997) 25-Hydroxyvitamin D3 1α-hydroxylase and vitamin D synthesis. Science 277 1827-1830.
145. Y. Tanaka, L. Castillo and H.F. DeLuca (1976) Control of renal vitamin D hydroxylases in birds by sex hormones. Proc. Natl. Acad. Sci. U. S. A. 73 2701-2705.
146. P.D. Thompson, P.W. Jurutka, C.A. Haussler, G.K. Whitfield and M.R. Haussler (1998) Heterodimeric DNA binding by the vitamin D receptor and retinoid x receptors is enhanced by 1, 25-dihydroxyvitmin D3 and inhibited by 9-cis-retinoic acid: Evidence for allosteric receptor interaction. J. Biol. Chem. 273 8483-8491.
147. M. Tomon, H.S. Tenenhouse and G. Jones (1990) 1, 25-Dihydroxyvitamin D3-inducible catabolism of vitamin D metabolites in mouse intestine. Am. J. Physiol. 258 G557-ggG563.
148. T.L. Towers, T.P. Staeva and L.P. Freedman (1999) A two-hit mechanism for vitamin D3-mediated transcriptional repression of the granulocyte-machrophage colony-stimulating factor gene: Vitamin D receptor competes for DNA binding with NFAT1 and stablizes c-jun. Mol. Cell. Biol. 19 4191-4199.
149. J.L. Underwood and H.F. DeLuca (1984) Vitamin D is not directly necessary for bone growth and mineralization. Am. J. Physiol. 246 E493-eeE498.
150. S.J. Van Cromphaut, M. Dewerchin, J.G. Hoenderop, I. Stockmans, E. Van Herck, S. Kato, R.J. Bindels, D. Collen, P. Carmeliet, R. Bouillon and G. Carmeliet (2001) Duodenal calcium absorption in vitamin D receptor-knockout mice: functional and molecular aspects. Proc. Natl. Acad. Sci. U. S. A. 98 13324-13329.
151. S.F. van de Graaf, J.G. Hoenderop, D. Gkika, D. Lamers, J. Prenen, U. Rescher, V. Gerke, O. Staub, B. Nilius and R.J. Bindels (2003) Functional expression of the epithelial Ca(2+) channels (TRPV5 and TRPV6) requires association of the S100A10-annexin 2 complex. EMBO J. 22 1478-1487.
152. R. Vennekens, J.G.J. Hoenderop, J. Prenen, M. Stuiver, P.H.G.M. Willems, G. Droogmans, B. Nilius and R.J.M. Bindels (2000) Permeation and gating properties of the novel epithelial calcium channel, ECaC. J. Biol. Chem. 275 3963-3969.
153. A. Villagra, F. Cruzat, L. Carvallo, R. Paredes, J. Olate, A.J. van Wijnen, G.S. Stein, J.B. Lian, J.L. Stein, A.N. Imbalzano and M. Montecino (2006) Chromatin remodeling and transcriptional activity of the bone-specific osteocalcin gene require CCAAT/enhancer-binding protein beta-dependent recruitment of SWI/SNF activity. J. Biol. Chem. 281 22695-22706.
154. L. Wada, R. Daly, D. Kern and B. Halloran (1992) Kinetics of 1, 25-dihydroxyvitamin D metabolism in the aging rat. Am. J. Physiol. 262 E906-eeE910.
155. Q. Wang, W. Yang, M.S. Uytingco, S. Christakos and R. Wieder (2000) 1, 25-Dihydroxyvitamin D3 and all-trans-retinoic acid sensitize breast cancer cells to chemotherapy-induced cell death. Cancer Res. 60 2040-2048.
156. Y.-Z. Wang and S. Christakos (1995) Retinoic acid regulates the expression of the calcium binding protein, calbindin-D28k. Mol. Endocrinol. 9 1510-1521.
157. Y.-Z. Wang, H. Li, M.E. Bruns, M. Uskokovic, G.A. Truitt, R. Horst, T. Reinhardt and S. Christakos (1993) Effect of 1, 25, 28-trihydroxyvitamin D2 and 1, 24, 25-trihydroxyvitamin D3 on intestinal calbindin-D9k mRNA and protein: Is there a correlation with intestinal calcium transport? J. Bone Miner. Res. 8 1483-1490.
158. R.H. Wasserman and C.S. Fullmer (1995) Vitamin D and intestinal calcium transport: Facts, speculations, and hypotheses. J. Nutr. 125 1971S-ss1979S.
159. R.H. Wasserman, C.A. Smith, M.E. Brindak, N. DeTalamoni, C.S. Fullmer, J.T. Penniston and R. Kumar (1992) Vitamin D and mineral deficiency increase the plasma membrane calcium pump of chicken intestine. Gastroenterology 102 886-894.
160. R.S. Weinstein, J.L. Underwood, M.S. Hutson and H.F. DeLuca (1984) Bone histomorphometry in vitamin D-deficient rats infused with calcium and phosphorus. Am. J. Physiol. 246 E499-eeE505.
161. G.K. Whitfield, J.-C. Hsieh, S. Nakajima, P.N. MacDonald, P.D. Thompson, P.W. Jurutka, C.A. Haussler and M.R. Haussler (1995) A highly conserved region in the hormone-binding domain of the human vitamin D receptor contains residues vital for heterodimerization with retinoid X receptor and for transcriptional activation. Mol. Endocrinol. 9 1166-1179.
162. R.J. Wiese, A. Uhland-Smith, T.K. Ross, J.M. Prahl and H.F. DeLuca (1992) Upregulation of the vitamin D receptor in response to 1, 25-dihydroxyvitamin D3 results from ligand induced stabilization. J. Biol. Chem. 267 20082-20086.
163. J. Winaver, D.B. Sylk, J.S. Robertson, T.C. Chen and J.B. Puschett (1980) Micropuncture study of the acute renal tubular effects of 25-hydroxyvitamin D3 in the dog. Miner. Electrolyte Metab. 4 178-188.
164. H. Yasuda, N. Shima, N. Nakagawa, S.I. Mochizuki, K. Yano, N. Fujise, Y. Sato, M. Goto, K. Yamaguchi, M. Kuriyama, T. Kanno, A. Murakami, E. Tsuda, T. Morinaga and K. Higashio (1998) Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): A mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. Endocrinology 139 1329-1337.
165. H. Yasuda, N. Shima, N. Nakagawa, K. Yamaguchi, M. Kinosaki, S.I. Mochizuki, A. Tomoyasu, K. Yano, M. Goto, A. Murakami, E. Tsuda, T. Morinaga, K. Higashio, N. Udagawa, N. Takahashi and T. Suda (1998) Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc. Natl. Acad. Sci. U. S. A. 95 3597-3602.
166. H. Yoshitake, S.R. Rittling, D.T. Denhardt and M. Noda (1999) Osteopontin-deficient mice are resistant to ovariectomy-induced bone resorption. Proc. Natl. Acad. Sci. U. S. A. 96 8156-8160.
167. T. Yoshizawa, Y. Handa, Y. Uematsu, S. Takeda, K. Sekine, Y. Yoshihara, T. Kawakami, K. Arioka, H. Sato, Y. Uchiyama, S. Masushige, A. Fukamizu, T. Matsumoto and S. Kato (1997) Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning. Nature Genet. 16 391-396.
168. J.M. Zelinski, D.E. Sykes and M.M. Weiser (1991) The effect of vitamin D on rat intestinal plasma membrane Ca-pump mRNA. Biochem. Biophys. Res. Commun. 179 749-755.
169. L.A. Zella, S. Kim, N.K. Shevde and J.W. Pike (2006) Enhancers located within two introns of the vitamin D receptor gene mediate transcriptional autoregulation by 1, 25-dihydroxyvitamin D3. Mol. Endocrinol. 20 1231-1247.
170. X.-Y. Zhao, L.H. Ly, D.M. Peehl and D. Feldman (1997) 1α, 25-Dihydroxyvitamin D3 actions in LNCaP human prostate cancer cells are androgen-dependent. Endocrinology 138 3290-3298.
171. C. Zierold, H.M. Darwish and H.F. DeLuca (1995) Two vitamin D response elements function in the rat 1, 25-dihydroxyvitamin D 24-hydroxylase promoter. J. Biol. Chem. 270 1675-1678.